The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Predicting response to immune checkpoint blockade in recurrent/metastatic head and neck squamous cell carcinoma using personalized circulating tumor DNA.
 
Daniel A. Ruiz Torres
No Relationships to Disclose
 
Ross D Merkin
No Relationships to Disclose
 
Julia Mendel
No Relationships to Disclose
 
Adam S. Fisch
No Relationships to Disclose
 
Thomas J Roberts
Employment - Bicara Therapeutics (I); Biocon
Leadership - Bicara Therapeutics (I); Biocon
Stock and Other Ownership Interests - Bicara Therapeutics (I); Biocon (I); Syngene Ltd. (I)
 
Manisha Jayandra Patel
No Relationships to Disclose
 
Jong Chul Park
Research Funding - A2 Biotherapeutics (Inst); ALX Oncology (Inst); Ankyra Therapeutics (Inst); InhibRx (Inst)
 
Amber Chevalier
Employment - NeoGenomics Laboratories
 
Clodagh Murray
Employment - NeoGenomics Laboratories
 
Lisa Gates
Employment - Invitae; NeoGenomics Laboratories
Stock and Other Ownership Interests - NeoGenomics (current shareholder), Invitae (previous), Guardant Health (previous)
 
Vasileios Efthymiou
No Relationships to Disclose
 
Christodoulos Pipinikas
Employment - NeoGenomics Laboratories
 
Lori J. Wirth
Consulting or Advisory Role - Bayer; Coherus Biosciences; Curie Therapeutics; Eisai; Exelixis; Lilly; Merck; METIS Precision Medicine; Morphic Therapeutic; Tome Biosciences
Research Funding - Checkmate Pharmaceuticals (Inst); Eisai (Inst); Lilly (Inst); Novartis (Inst)
Expert Testimony - Eisai
Other Relationship - PDS Biotechnology
 
Daniel Faden
Stock and Other Ownership Interests - Illumina; Qiagen; Roche
Honoraria - Focus Medical Communications; Merck; Noetic
Consulting or Advisory Role - Chrysalis Biomedical Advisors
Speakers' Bureau - Arcadia Science
Research Funding - BostonGene; Bristol Myers Squibb Foundation; Calico; NeoGenomics Laboratories; NeoGenomics Laboratories; Predicine